Jill Morris, Ph.D.

Technology development for gene-targeted therapies; hydrocephalus and normal pressure hydrocephalus, neural tube defects (spina bifida); various rare diseases including inborn errors of metabolism, lysosomal storage disorders, leukodystrophies, brain iron accumulation disorders (NBIA), copper metabolism disorders, congenital disorders of glycosylation, mitochondrial disorders, and peroxisomal disorders), pediatric genetic vasculopathies, Ataxia Telangiectasia and basic studies on ATM mutation related DNA damage and DNA repair.

Additional Keywords: Lesch-Nyhan Disease; Phenylketonuria (PKU) Deficiency; Smith-Lemli-Opitz syndrome; Wilson’s disease; Menkes; adult-onset leukoencephalopathy; adrenoleukodystrophy; Aicardi Goutieres syndrome; Alexander’s disease; Canavan; Krabbe; metachromatic leukodystrophy; Pelizaeus-Mezbacher; vanishing white matter disease